Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penfluridol for Relapsed/Refractory Small Cell Lung or Cervical Cancer
NCT07206563Phase 2Not yet recruiting
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of penfluridol in Small Cell Lung Cancer (SCLC), Small-Cell Cervical Cancer (SCCC). Planned start Oct 2025; status: not yet recruiting.
02
Drugs
penfluridol
03
Conditions
Small Cell Lung Cancer (SCLC)Small-Cell Cervical Cancer (SCCC)
Beyond the preview
Go deeper on NCT07206563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206563.